COPD is a progressive lung disease causing persistent airflow limitation, primarily from emphysema and chronic bronchitis. Smoking is responsible for 85% of cases; symptoms include chronic cough, sputum production, and exertional dyspnea.
Salbutamol is a short-acting beta-2 agonist (SABA) used as a reliever inhaler to rapidly reverse bronchoconstriction in asthma and COPD.
Terbutaline is a short-acting beta-2 agonist (SABA) used as a reliever inhaler to rapidly reverse bronchoconstriction in asthma and COPD.
Fenoterol is a short-acting beta-2 agonist (SABA) used as a reliever inhaler to rapidly reverse bronchoconstriction in asthma and COPD.
Salmeterol is a long-acting beta-2 agonist (LABA) used as a maintenance bronchodilator in asthma and COPD, always in combination with an inhaled corticosteroid.
Formoterol is a long-acting beta-2 agonist (LABA) used as a maintenance bronchodilator in asthma and COPD, always in combination with an inhaled corticosteroid.
Indacaterol is a long-acting beta-2 agonist (LABA) used as a maintenance bronchodilator in asthma and COPD, always in combination with an inhaled corticosteroid.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: